Introduction
Most pathogenic microorganisms are either restricted to the mucosal membranes or need to transit across the mucosal barrier during the early steps of infection. Thus, the elicitation of mucosal immune responses after vaccination is highly desired. A potential approach to achieve this aim is the use of attenuated Salmonella as carrier for heterologous antigens [1] .
The translocation of virulence factors into target cells plays a central role in the pathogenesis process. This virulence trait is linked to the presence of type III secretion systems (TTSS). The Salmonella pathogenicity island 1 (SPI-1) encodes a TTSS required for bacterial invasion of epithelial cells; whereas the SPI-2 codes for a TTSS which is necessary for bacterial intracellular growth [2] . Salmonella carrying mutations in the SPI-2-encoded TTSS are highly attenuated in virulence, showing reduced rates of intracellular survival and replication [3] . Oral vaccination with Salmonella carriers with a mutation in sseC, an effector protein secreted by SPI-2, resulted in the stimulation of strong immune responses [4] .
Secreted effector proteins might facilitate Salmonella evasion of host clearance mechanisms.
For example, bacteria can avoid the immune system by surviving and replicating within macrophages and dendritic cells (DC) [5] . Long-term residence and replication within host cells appear to be essential for virulence and chronic infection. Previous studies indicated that Salmonella occupies an altered vacuolar compartment within professional antigen presenting cells (APC) [6] . Bacteria can also trigger rapid apoptosis in macrophages through the SPI-1-encoded SipB protein [7] . However, Salmonella can also promote SPI-1-independent delayed apoptosis in macrophages. This process seems to require a functional SPI-2 TTSS [8] . We hypothesize that Salmonella-mediated effects on APC may lead to impaired presentation of bacterial antigens, which in turn may affect microbial clearance during natural infections.
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The SPI-5-encoded SopB protein is secreted and translocated into the cytosol through Thus, in the present study we evaluated the capacity of attenuated Salmonella enterica Serovar Typhimurium strains (i.e. sseC, phoP and aroA) and derivatives carrying a second mutation in the sopB locus to affect the activation, maturation and antigen presentation capacities of bone marrow-derived murine DC. The results suggest that Salmonella spp.
could also escape the host immune system by a SopB-dependent mechanism, leading to impaired antigen presentation by DC. Immunization studies also showed that this escape mechanism can be subverted to optimize the performance of live vaccines, since the introduction of an additional sopB mutation in different attenuated carrier strains resulted in the stimulation of improved immune responses.
Material and methods

Construction of Salmonella derivatives
Restriction and modification enzymes were purchased from New England Biolabs (Frankfurt, Germany 
Experimental growth conditions
For antigen presentation studies Salmonella grown in Brain heart infusion broth supplemented with ampicillin (100 µg/ml) and/or chloramphenicol (50 µg/ml) were pelleted (3000 x g) and resuspended in Dulbecco modified Eagle medium (DMEM, Gibco BRL, Karlsruhe) supplemented with 10% fetal calf serum (FCS, Greiner). For immunization studies bacteria transformed with pLS1000 were grown in Luria Bertani broth supplemented with ampicillin.
Infection of DC
Bone marrow-derived DC from BALB/c mice (Harlan Winkelmann, Borchen) were prepared as previously described [16] , resuspended in DMEM with GM-CSF (5x10 4 U/ml) and seeded in 6-well plates (5x10 6 cells/well). Bacteria were added at a multiplicity of infection 10:1 and plates were incubated for 2 h. After washing, cells were incubated with gentamycin (100 μg/ml; Sigma) for 22 h and further analyzed by flow cytometry or used as APC.
Flow cytometric analysis
Staining of DC was performed as previously described [16] , using FITC-labeled monoclonal antibodies against MHC-I (SF1-1.1), MHC-II (AMS-32.1), CD80 (16-10A1), CD86 (GL1), CD40 (3/23) and CD54 (3E2), and PE-labeled anti-CD11c (HL3) from BD Pharmingen.
Apoptotic and necrotic cells were stained using Alexa Fluor 488-conjugated annexin V (MoBiTec) and 7-Amino-Actinomycin D (BD Pharmingen), respectively. FACS analysis was performed using a FACSort and the CellQuest software (Becton Dickinson, San Jose, CA) with gating on CD11c positive cells (acquisition of 50,000 events).
Antigen presentation tests
Spleens from the TCR-HA transgenic mice, which express T cell receptors (TCR) specific for the 111-119 peptide from the influenza HA in the context of I-E d [17] 
Immunization studies
Female BALB/c mice (n=5) were orally immunized on day 1, 14 and 28 with 1x10 9 colony forming units of Salmonella. Animals were sacrificed on day 38, and sera and intestinal lavages were tested for ß-galactosidase-or lipopolysaccharide-specific antibodies by ELISA [18] . 
Statistical analysis
The statistic significance of the observed differences was evaluated by the Χ 2 -or the Student's t-test (SigmaStat 3.1; Systat). Differences were considered significant at P < 0.05.
Results
Salmonella sopB derivatives exhibit an impaired cytotoxic effect on infected DC
To evaluate the effect of S. enterica derivatives on DC viability, cells infected with and apoptotic cells (P < 0.05) was observed after infection with the sseC sopB (4.7 and 37.7%, respectively) or the aroA sopB double mutant (9.3 and 37.1%).
DC infected with the sopB mutant showed improved expression of activation markers
To evaluate the influence of Salmonella infection on DC maturation and activation, immature cells were infected with the bacterial strains and further analyzed by flow cytometry. In comparison to control cells, DC infected with wild type Salmonella showed an up-regulated expression of adhesion (e.g., CD40), co-stimulatory (e.g., CD80, CD86), and MHC-II molecules ( Fig. 1 and Table 3 ). Similar results were observed when attenuated sseC and phoP mutants were used ( Fig. 1 and Table 3 ). Interestingly, cells infected with the double mutants sseC sopB or phoP sopB exhibited a significantly (P < 0.05) higher expression of CD54, CD80, CD86 and MHC-I molecules than DC infected with the sseC and phoP single
mutants. Similar results were observed when DC were infected with the aroA and aroA sopB derivatives (data not shown). those observed using non-infected DC (Fig. 2, A) . When DC were infected with the sseC sopB double mutant, a significant increase in T cell activation was observed with respect to that obtained using as APC DC infected with the sseC mutant (P< 0.05). Similar results were obtained using DC infected with the phoP and the phoP sopB mutants (Fig. 2, B ). These results demonstrate that antigens delivered by SopB deficient Salmonella were more efficiently processed and presented to antigen-specific T cells by infected DC in vitro. DC infected with the sseC sopB mutant exhibited enhanced antigen presentation functions, thus we evaluated the capacity of this strain as vaccine carrier. Mice were orally immunized with 1x10 9 colony forming units of Salmonella strains mutated either in the sseC or the sseC sopB loci expressing the model antigen β-galactosidase. Due to its toxicity, immunization using the single mutant sopB was omitted. Sera from animals vaccinated with the sseC sopB mutant showed anti-lipopolysaccharide and anti-β-galactosidase IgG responses similar to those observed in mice receiving the sseC mutant (not shown). However, incorporation of the sopB mutation resulted in the stimulation of stronger secretory IgA responses (Fig. 3, A) .
DC infected with
Attenuated
Interestingly, when the subclass distribution of β-galactosidase-specific serum IgG was analyzed, it was clear that immunization with the sseC sopB mutant led to a dominant IgG1 response (i.e., Th2-biased), whereas vaccination with the sseC-deficient strain yielded an IgG2a-dominated pattern (Th1-biased, Fig. 3 , B) [19] . This is in agreement with the improved secretory IgA responses detected in these animals.
We also evaluated the capacity of CD8 + T cells to produce IFNγ in response to a peptide encompassing a MHC class I-restricted immunodominant epitope of β-galactosidase.
Approximately 7.5-fold more IFNγ-secreting cells were detected in the animals vaccinated with the double mutant sseC sopB than in mice immunized with sseC (Fig. 3, C resulted in the elicitation of 3.3-and 2.4-fold stronger antibody responses against β-galactosidase, respectively (Fig. 3, D) .
Discussion
Attenuated Because of the critical involvement of DC in Salmonella uptake and dissemination, it is essential to elucidate if wild type and attenuated Salmonella strains can affect their biological functions. On the one hand, APC may offer bacteria a potential niche in which they can survive and replicate. On the other hand, Salmonella can also trigger cell death in macrophages and DC, thereby affecting the antigen presentation process [6, 21] . Therefore, these two mechanisms might contribute to the immune escape of this pathogen. Rapid activation of programmed cell death in macrophages depends on the SPI-1-encoded TTSS, which is active in Salmonella displaying an invasive phenotype [6, 7] . However, macrophages can be also killed in a delayed SPI-1-independent manner, when Salmonella express the SPI-
2-encoded TTSS [8].
Our studies demonstrated that Salmonella defective in the synthesis of the SPI-2-encoded effector protein SseC promote apoptosis in infected DC to a similar extent to the wild type parental bacteria. This is particularly clear when Salmonella were grown until they
reach the exponential growth phase, in which the SPI-1-encoded TTSS is mainly active. On the other hand, DC infected with a Salmonella sseC mutant carrying an additional mutation in the SPI-1-translocated effector protein SopB showed both increased membrane integrity and viability. These results can be explained, at least in part, by differences in the infective capacity of the Salmonella mutants. In accordance to previous studies we observed a similar invasiveness in DC for wild type Salmonella and its attenuated derivatives [22, 23] .
Concerning the sopB mutant, there are contrasting data in the literature, which suggest a non affected invasiveness in DC [24, 25] and impaired survival in macrophages [26] . In our hands, a significantly reduced number of viable intracellular bacteria was observed when DC were infected with the double mutants (data not shown).
The effector protein SopB is delivered into the cytosol, where it acts as an inositol phosphatase. It was shown that this protein affects different processes, such as the rearrangement of cytoskeletal proteins, host cell invasion and chloride homeostasis [9,10].
SopB is associated with the host cell membrane via hydrophobic interactions and is required for the elimination of phosphatidylinositol-4,5-biphosphate from invaginating host cell membranes [27] . The formation and fusion of Salmonella-containing vacuoles is also influenced by SopB [26] . Due to its broad spectrum of substrate specificities, the identity of the in vivo relevant substrates and the exact molecular functions of SopB in the pathogenesis process are still a matter of discussion. However, our results suggest that a deficient production of SopB results in reduced bacterial survival within DC and increased viability and functionality of APC. This hypothesis is further supported by the findings of Knodler et al., who observed an anti-apoptotic activity of SopB in Salmonella-infected epithelial cells [25] . This can explain, at least in part, the observed improvement in the T cell-activation capacity of DC infected with the double mutants.
DC play a key role during the induction of adaptive immune responses, since they constitute the bridge between innate and adaptive immunity. After encountering invading microbes in peripheral tissues, immature DC capture antigens and migrate into the T celldependent areas of the secondary lymphoid tissues. During migration, they undergo a maturation process, which is characterized by morphological and functional changes. Only mature DC have high surface expression of MHC and co-stimulatory molecules, which in turn are essential for efficient T cell activation. An up-regulated expression of activation markers was already observed on DC after infection with Salmonella grown to the stationary phase [28, 29] . In this study, we demonstrated an enhanced expression of these molecules on DC infected with exponentially growing wild type bacteria. These conditions seem to mimic more closely the situation of rapid replication occurring during systemic dissemination.
Similar results were obtained using attenuated Salmonella carrying a mutation in the gene aroA, which is involved in the biosynthesis of aromatic compounds, as well as bacteria defective in the production of the SPI-2-encoded effector protein SseC or the PhoP/Q twocomponent regulatory system. When DC were infected with aroA-, sseC-and phoPderivatives carrying an additional mutation on sopB, we observed a significant increment in the expression levels of adhesion, (i.e. CD54), co-stimulatory (i.e. CD80, CD86) and MHC class I molecules.
These results suggest that the presence of a sopB mutation in attenuated bacteria results not only in an improved viability of infected DC, but also in their increased expression of surface molecules that are critical for antigen presentation. Thus, we evaluated the influence of the sopB mutation on the antigen presenting capacity of infected DC. To this end, antigen presentation studies were performed using Salmonella expressing a polypeptide encompassing epitopes recognized by T cells of HA-transgenic mice. DC infected with Salmonella carrying a mutation on the sseC or phoP genes were able to stimulate an antigen-specific proliferation of T cells. However, when cells were infected with Salmonella derivatives carrying an additional mutation in the sopB locus, a significantly enhanced activation of T cells was observed. Thus, the incorporation of a mutation in the sopB locus improves the capacity of infected DC to process a heterologous antigen and present it to T cells. Studies from Cheminay et al. suggested that DC infected with Salmonella can suppress antigen-dependent T-cell proliferation by a SPI-2-dependent mechanism [30] . However, in these in vitro studies exogenous antigen was added to infected DC. This scenario is clearly different from our studies in which the antigen expression was performed in vivo by Salmonella itself, thereby mimicking the conditions occurring during infection or vaccination. However, it seems clear that several bacterial factors might affect DC viability and function.
The improved activation, maturation and antigen presentation capacities of DC infected with the sopB derivatives prompted us to evaluate if the sopB mutation can be incorporated into attenuated carrier strains to increase their performance. Previous studies showed that a Salmonella vaccine carrier strain with a mutation in the sseC gene promotes strong humoral and cellular immune responses against the model antigen β-galactosidase after oral immunization [4] . Thus, we compared the immune responses stimulated using a Salmonella sseC mutant as carrier, with those obtained using the double mutant sseC sopB. In agreement with the in vitro antigen presentation studies, the incorporation of the sopB mutation led to the elicitation of significantly stronger humoral and cellular immune responses (Fig. 3) . Similar results were also obtained when the sopB mutation was combined with mutations in the phoP and aroA genes, respectively. This suggests that the observed effect is not restricted to a single type of attenuated mutant.
CD4 + T cells can differentiate into two distinct types of effector cells, Th1 cells that regulate cell-mediated immunity and Th2 cells, which regulate humoral immune responses
Link C. et al. [19] . While Th2-type responses are mainly protective against certain parasites, Th1-type responses enhance the microbicidal activity of macrophages, thereby facilitating the clearance of intracellular pathogens. Interestingly, the analysis of the IgG subclasses showed that mainly IgG1 was stimulated by the double mutant sseC sopB (i.e. Th2 dominant pattern), whereas the sseC deficient Salmonella promoted a Th1-like response. Thus, it seems that the incorporation of additional mutations can also be exploited to modulate the quality of the immune responses elicited using live carriers. Although additional work will be required to elucidate the underlying mechanisms.
In conclusion, the obtained results suggest that Salmonella can also escape the host immune system by a SopB-mediated mechanism, in which the antigen presentation capacities of DC are impaired. These results not only define a new potential immune escape mechanism of this important pathogen, but also demonstrate that this mechanism can be subverted to optimize the immune responses elicited using live attenuated Salmonella as vaccine carriers. Results are expressed as percentages of the total number (i.e., 50,000) of viable gated CD11c 
